Related Experiment Video
Updated: Jun 12, 2026
Technique of Porcine Liver Procurement and Orthotopic Transplantation using an Active Porto-Caval Shunt
Published on: May 7, 2015
ELISA-based detection of C4d after liver transplantation--a helpful tool for differential diagnosis between acute
Maximilian Schmeding1, Stefan Kienlein, Christoph Röcken
1Department of General, Visceral and Transplantation Surgery, Charité Campus Virchow Klinikum, Berlin, Germany. maximilian.schmeding@charite.de
Insights
Distinguishing acute rejection from Hepatitis C recurrence after liver transplantation (LTX) is vital. While C4d showed promise in prior studies, ELISA testing of cryo-preserved biopsies failed to confirm its diagnostic value for differentiating these conditions.
Area of Science:
- Transplantation immunology
- Hepatology
- Complement system research
Background:
- Hepatitis C virus (HCV) recurrence is a primary cause of liver graft failure post-transplantation.
- Accurate differentiation between acute cellular rejection (ACR) and HCV recurrence is critical for appropriate treatment and graft survival.
- Current diagnostic methods, including liver biopsy histology, struggle to reliably distinguish ACR from HCV recurrence.
Purpose of the Study:
- To prospectively evaluate the utility of C4d complement deposition as a biomarker for differentiating acute rejection from Hepatitis C recurrence in liver transplant recipients.
- To compare ELISA-based C4d quantification in cryo-preserved liver biopsies with previous immunohistological findings in paraffinized tissues.
Main Methods:
- Prospective analysis of cryo-preserved liver biopsy specimens from liver transplant (LTX) patients.
- Enzyme-linked immunosorbent assay (ELISA) was used to measure C4d concentrations.
- Patient groups included those with acute rejection, HCV recurrence, and controls with no pathological alterations.
Main Results:
- No significant differences in C4d concentrations were detected between groups using ELISA on cryo-preserved liver tissue.
- These findings contrast with previous retrospective immunohistological studies on paraffinized tissues.
- ELISA-based C4d evaluation of cryo-preserved biopsies did not prove effective in distinguishing ACR from HCV recurrence.
Conclusions:
- The diagnostic value of C4d as a marker for differentiating acute rejection from Hepatitis C recurrence in liver transplantation remains uncertain when assessed by ELISA on cryo-preserved tissue.
- Further research using different methodologies or tissue preservation techniques may be needed to clarify the role of C4d in this clinical context.
Abstract:
Hepatitis-C is the most common indication for liver transplantation. Recurrence of HCV is universal leading to graft failure in up to 40% of all patients. The differentiation between acute rejection and recurrent hepatitis-C is crucial as rejection treatments are likely to aggravate HCV-recurrence. Histological examination of liver biopsy remains the gold standard for diagnosis of acute rejection but has failed in the past to distinguish between acute rejection and recurrent hepatitis-C. In a retrospective study we have recently reported that C4d as a marker of the activated complement cascade is detectable in a hepatic specimen in acute rejection after liver transplantation and may serve as a valuable tool in differential diagnosis between ACR and HCV-recurrence. We performed a prospective analysis by ELISA measurement of C4d concentration in cryo-preserved liver biopsies of LTX patients who had either experienced acute rejection, hepatitis-C recurrence or displayed no pathological alterations (controls). Opposed to our immunohistologically based findings in paraffinized tissue we were unable to detect significant differences of C4d concentration in ELISA of cryo-preserved liver tissue. Consequently the role and potential value of C4d as a diagnostic marker may not be determined using ELISA-based tissue evaluation.
